Nine months into 2024, the search for effective neurodegenerative disease therapies continues, yielding a mix of promising advances and frustrating setbacks. After something of a lull in the 1990s and early 2000s, research into novel treatments for neurodegenerative diseases has surged back to life. One factor propelling the trend is the uptick in neurodegenerative disease…
How DeepCure taps reinforcement learning for first-in-class therapies
Boston-based DeepCure may be an AI-focused biotech, but it sets itself apart by focusing its AI-powered platform on historically challenging drug targets that have eluded traditional approaches. “While AI in drug discovery is often viewed as a means to accelerate and reduce costs, our focus at DeepCure is on achieving true novelty in drug development…
20 novel therapies set to shape the landscape of medicine in 2023
The year 2023 is poised to bring an array of novel therapies that could significantly impact the treatment of several diseases. This article considers 20 promising medications that could generate significant sales for the industry. From hypertension to cancer, Alzheimer’s to hemophilia, these novel therapies could potentially change the lives of millions worldwide. About one-third…